Abstract
1. Patients with neutropenic fever who are found to be low risk based on clinical judgment and MASCC or CISNE score, can be discharged home with oral antibiotics and close follow up. Those who are found to be high risk, should be admitted for IV antibiotics. 2. Patients who are taking an oral fluoroquinolone for prophylactic therapy are not candidates for fluoroquinolone therapy for treatment of neutropenic fever and should be admitted to the hospital for IV antibiotics. 3. Patients who use a feeding tube as their primary route for nutrition and medication are not appropriate for outpatient neutropenic fever treatment. 4. If a patient is monitored in the ED and continues to be febrile despite administration of antibiotics, the patient may need to be admitted for IV antibiotics versus being discharged home on oral antibiotics. 5. If a patient is known to have a history of multidrug resistant organisms consider consulting Infectious Disease for assistance in antibiotic selection.
| Original language | English (US) |
|---|---|
| Title of host publication | Coresource 4 |
| Publisher | Cambridge University Press |
| Pages | 162-165 |
| Number of pages | 4 |
| ISBN (Print) | 9781009500791 |
| DOIs | |
| State | Published - 2026 |
ASJC Scopus subject areas
- General Medicine
- General Nursing
Fingerprint
Dive into the research topics of 'Productive Cough'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS